metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Letter to the Editor
Journal Information
Vol. 4. Issue 4.
Pages 289 (October - December 2005)
Share
Share
Download PDF
More article options
Vol. 4. Issue 4.
Pages 289 (October - December 2005)
Open Access
Letter to the Editor
Visits
666
Jesús Aguirre-García1,
Corresponding author
familiaaguirre@mexis.com

Address for correspondence: E-mail:
1 Departamento de Patología. Hospital General de México. Facultad de Medicina Universidad Nacional Autónoma de México. México, D.F.
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text

In the article by Ruelas-Villavicencio et al1 that evaluates a hepatocellular carcinoma (HCC) surveillance program the authors concluded that male predominance was not observed for this neoplasm in their series (male:female ratio was 1.2:1) and that only 42% of thier patients showed “signs of cirrhosis”, which is not far from the 56% found by Mondragón et al in their Mexican series of HCC patients.2

The difference between the findings in this paper and those described in the literature is due to the methods used in diagnosing hepatic cirrhosis (fine needle aspiration biopsy, or clinical presentation and laboratory abnormalities associated to endoscopic and or imaging findings) and the inclusion criteria for the cases.

Fine needle aspiration biopsy is not an useful method in the diagnosis of hepatic cirrhosis,3 and a conclusion cannot be supported with the diagnosis of “findings compatible with cirrhosis” (it was the diagnosis in 30% of the patients with liver biopsy).

Tumors were classified as well differentiated HCC, intermediately differentiated HCC, poorly differentiated HCC, compatible with HCC, fibrolamellar carcinoma, mixed carcinoma, and in 76 cases histological findings were not described. Again, a conclusion cannot be supported in cases diagnosed as “compatible with HCC” or in cases with unknown histological changes (76 cases). On the other hand, fibrolamellar carcinoma is a different disease than “ordinary” or “common” liver cell carcinoma; these tumors have. different etiology, pre-cancerous lesions, clinical presentation and biological behaviour, although both are of liver-cell origin and are malignant. Also mixed carcinoma is a different tumor than ordinary HCC.

Mondragón et al2 reported that cirrhosis was demonstrated in 52% of the patients with HCC (not 56%), but they included common liver cell carcinoma, fibrolamellar carcinoma, cholangiocarcinoma and “cystic tumors”.

In an autopsy series published by Ramos-Martínez et al in México, in 19824 (from a third health care center), there were 88 cases of common liver cell carcinoma. The male:female ratio was 3:1, the average age was 64 years, and in 81 cases (92%) the liver showed cirrhosis. These findings are in agreement with what has been pointed out by Anthony: “constant risk factors in all parts of the world are male sex, age, and cirrhosis”.5

References
[1.]
Ruelas-Villavicencio A.L., Vargas-Vorácková F..
In whom, how and how often is surveillance for hepatocelullar carcinoma cost-effective?.
Ann Hepatol, 3 (2004), pp. 152-159
[2.]
Mondragón-Sánchez R, Ochoa-Carrillo F.J., Ruiz-Molina J.M., Herrera-Goepfert R, Oñate-Ocaña L.F., Aiello-Crocifoglio V..
Carcinoma hepatocelular. Experiencia en el Instituto Nacional de Cancerología..
Rev Gastroenterol Mex, 62 (1997), pp. 34-40
[3.]
Perry M.D., Johnson WW..
Needle biopsy of the liver for the diagnosis of nonneoplastic liver disease..
Acta Cytologica, 29 (1985), pp. 385-390
[4.]
Ramos-Martínez E, González-Quezada A, Castillo-Foncerrada G, Velasco-Avilés F, Aguirre-García J..
Carcinoma primario del hígado. Estudio anatomoclínico de 109 casos..
Rev Invest Clín (Méx), 34 (1982), pp. 133-143
[5.]
Anthony PP..
Tumours and tumour-like lesions of the liver and biliary tract: aetiology epidemiology and pathology. In:.
Pathology of the Liver, 4th ed, pp. 711-775
Copyright © 2005. Fundación Clínica Médica Sur, A.C.
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos